Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Zenas BioPharma, Inc. ZBIO

Full chart Compare
Set alert

Price alert · ZBIO

All alert types
28.46 USD +0.08 (+0.28%)

At closeNov 4, 2026, 4:01 PM EST

28.46 0.00 0.00%

After hours · Nov 4, 4:01 PM ET

28.01 Day range 29.80
13.50 52-week range 44.60
YTD
-21.62%
1 year
-4.97%

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 47.88 +68.2% upside
Target (low)
32.00
Target (mean)
47.88
Target (high)
59.00
Ratings (0m) 8 7 buy · 1 hold · 0 sell
  • Strong buy0
  • Buy7
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 8
  • 1 month ago 8
  • 2 months ago 8

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ZBIO analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.27-1.31 – -1.23-1.22-4.1%00.0%2
Next quarter-1.28-1.31 – -1.25-1.39+7.9%14.07M0.0%2
Current year-5.62-5.83 – -5.40-4.83-16.2%12.26M+22.6%2
Next year-4.66-5.11 – -4.21-5.62+17.0%57.93M+372.5%2

Upgrades and downgrades

The latest rating changes

ZBIO analyst upgrades and downgrades
DateFirmActionFromTo
Oct 13, 2026HC Wainwright & Co.ReiteratedBuyBuy
Sep 30, 2026CitigroupMaintainedBuyBuy
Sep 30, 2026WedbushReiteratedOutperformOutperform
Sep 30, 2026HC Wainwright & Co.ReiteratedBuyBuy
Aug 14, 2026Morgan StanleyMaintainedEqual-WeightEqual-Weight
Aug 14, 2026GuggenheimReiteratedBuyBuy
Aug 14, 2026WedbushReiteratedOutperformOutperform
May 15, 2026HC Wainwright & Co.ReiteratedBuyBuy
May 14, 2026Morgan StanleyMaintainedEqual-WeightEqual-Weight
Mar 17, 2026CitigroupMaintainedBuyBuy
Mar 17, 2026GuggenheimMaintainedBuyBuy
Mar 17, 2026Morgan StanleyMaintainedEqual-WeightEqual-Weight
Mar 17, 2026HC Wainwright & Co.ReiteratedBuyBuy
Feb 10, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jan 6, 2026Morgan StanleyDowngradeOverweightEqual-Weight
Dec 22, 2025WedbushReiteratedOutperformOutperform
Nov 26, 2025Evercore ISI GroupInitiated—Outperform
Nov 13, 2025Morgan StanleyMaintainedOverweightOverweight
Oct 28, 2025CitigroupMaintainedBuyBuy
Oct 28, 2025Morgan StanleyMaintainedOverweightOverweight
Oct 28, 2025HC Wainwright & Co.MaintainedBuyBuy
Oct 9, 2025WedbushMaintainedOutperformOutperform
Oct 9, 2025HC Wainwright & Co.ReiteratedBuyBuy
May 16, 2025HC Wainwright & Co.ReiteratedBuyBuy
Mar 20, 2025WedbushInitiated—Outperform
Mar 12, 2025GuggenheimReiteratedBuyBuy
Mar 12, 2025HC Wainwright & Co.ReiteratedBuyBuy
Feb 4, 2025Wolfe ResearchInitiated—Outperform
Dec 16, 2024HC Wainwright & Co.Initiated—Buy
Dec 11, 2024Morgan StanleyMaintainedOverweightOverweight